CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...